Pathologic Outcomes in Prostate Cancer Cases Worsened During Pandemic
Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.
Prostatectomy
Intense Neoadjuvant ADT May Not Improve Post-RP Outcomes in High-Risk Prostate Cancer
Neoadjuvant androgen deprivation therapy prior to prostate cancer surgery is feasible, investigators noted.
Prostate Cancer Survival Rates Vary by Gleason Grade Group 5 Pattern
Biopsy Gleason patterns 4+5, 5+4, and 5+5 should be given separate consideration in pretreatment risk stratification, according to investigators.
PLND Extent During Prostate Surgery Linked With Perioperative Complications
The technical challenges and potential complications of extended PLND warrant careful consideration, according to investigators.
Prostate, Kidney, and Pancreas Surgery Utilization Rates Differ by Income
Study findings corroborate previous research linking higher income with increased healthcare utilization.
Salvage Prostatectomy Complication Rates Differ by Primary PCa Therapy
Primary focal and radiation therapy for prostate cancer are associated with different rates of perioperative complications and long-term urinary continence recovery.
7 Myths About Prostate Cancer Debunked
Despite how common prostate cancer is in American men, misconceptions about its symptoms, detection, treatment, and management persist.
Same-Day Robotic Urologic Surgery During the COVID-19 Crisis Not Riskier
A single-institution study found no significant increase in the risk for complications or readmissions between patients who underwent robotic urologic surgery before and during the COVID-19 pandemic.
Salvage Therapies for Radiorecurrent Prostate Cancer Offer Similar RFS
Surgical and nonsurgical local salvage treatments for prostate cancer (PCa) that recurs following radiation therapy offer similar 5-year recurrence-free survival (RFS) rates, but re-irradiation appears to result in less toxicity, according to a new meta-analysis. A team led by Amar U. Kishan, MD, of the University of California, Los Angeles, analyzed data from 150 studies…
Study: No Need to Rush Surgery for High-Risk Prostate Cancer
Delaying radical prostatectomy for high-risk clinically localized prostate cancer for up to 6 months does not increase the risk for adverse pathologic outcomes, a study found.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...